SpaceX Successfully Launches Starship on Second Attempt After Previous Scrub Food Insecurity Levels Surpass Pandemic Peaks New York Fed Survey Reveals Apples AI Roadmap Faces Pivotal Test at Upcoming WWDC Starbucks Turnaround Questioned After AI Initiative Stumbles Berkshire Hathaway Boosts Alphabet Stake Initiates Delta Air Lines Position Indias Coffee Production for 202627 Could Decline 4 Due to Weather Concerns LDI Q1 2026 Earnings EPS Misses Estimates by Wide Margin Shares Rise Despite Loss Finward Bancorp FNWD Q1 2026 Earnings EPS Misses Expectations but Stock Ticks Higher Argan Inc AGX Q1 2026 Earnings EPS Surges 737 Above Estimates Shares Climb Nearly 2 ADTN Q1 2026 Earnings Earnings Beat Estimates Significantly Stock Jumps Catalyst Pharmaceuticals Inc CPRX Q1 2026 Earnings EPS Beats Estimates by 75 Stock Edges Slightly Lower HeartSciences Inc HSCS Q1 2026 Earnings WiderThanExpected Loss Narrows on Strong Cost Control Shares Rally Coeptis Therapeutics Holdings Inc COEP Holds Steady Near Support After Flat Trading Day BEPJ Edges Higher as Perpetual Preferred Note Shows Resilience at 2499 Ferrari RACE Faces Sharp Pullback Key Support Levels in Focus Polaryx Therapeutics PLYX Surges Nearly 20 Key Levels to Watch After the Breakout AMSC Faces Resistance After Sharp Decline Key Levels to Watch UONE Q1 2026 Earnings Net Loss of 069 Per Share as Stock Drops 66 HTB Q1 2026 Earnings EPS Surges Past Estimates with a 20 Beat Alta Equipment Group Inc ALTG Q1 2026 Earnings EPS Miss Widens as Losses Deepen WDS Q4 2025 Earnings EPS Beats Estimates by 338 as Strong Operational Performance Outweighs Weak Revenue Environment Kairos Pharma Ltd KAPA Q1 2026 Earnings EPS Misses Estimates Amid Ongoing ClinicalStage Operations STVN Q1 2026 Earnings EPS Surpasses Estimates by Over 5 Restaurants Experiment With PayWhatYouWant Pricing as DiningOut Declines Processa Pharmaceuticals PCSA Q4 2025 Earnings EPS Misses Estimates by a Wide Margin as PreRevenue Biotech Advances Pipeline Veritone VERI Presses Lower Testing Key Support at 19 After 43 Decline